Sold as Univasc. Every FDA application for this active ingredient: 1 branded and 4 generic.
As of Nov 16, 2026, FDA lists 5 applications for Moexipril Hydrochloride (sold as Univasc), first approved Apr 19, 1995, with 0 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Moexipril HCl | Part D | $542K | -41% | 2,170 |
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Chronic Kidney Disease, Type 2 Diabetes · Baylor Research Institute | Phase 4 | Enrolling by invitation | Apr 23, 2026 |
| Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort StudyPost-stroke Pneumonia · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | — | Not yet recruiting | Dec 4, 2025 |
| Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World StudySacubitril/Valsartan, Hypertension · Beijing Friendship Hospital | — | Recruiting | Aug 12, 2022 |
| Apr 19, 1995 | UnivascNDA 20312 · New molecular entity | Ucb Inc | 23 | Discontinued |
| May 8, 2003 | Moexipril HydrochlorideANDA 76204 | Teva | 4 | Marketed |
| Nov 30, 2006 | Moexipril HydrochlorideANDA 77536 | Chartwell Rx | 0 | Marketed |
| Jun 2, 2008 | Moexipril HydrochlorideANDA 78454 | Apotex Inc | 2 | Discontinued |
| Mar 30, 2010 | Moexipril HydrochlorideANDA 90416 | Glenmark Pharms Ltd | 3 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA